drugset / Trial / NCT01525290

Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke

NCT01525290 ↗

Phase 3 Completed 501 enrolled University Medical Center Hamburg-Eppendorf
RandomizedParallel-groupDouble-blindTreatment

Summary

WAKE-UP is an investigator initiated European multicenter randomized controlled clinical trial of MRI based thrombolysis in acute stroke patients with unknown time of symptom onset, e.g. due to recognition of stroke symptoms on awakening. Objective of WAKE-UP is to prove efficacy and safety of MRI-based intravenous thrombolysis with Alteplase in patients waking up with stroke symptoms or patients with otherwise unknown symptom onset.

Timeline

Start
2012-09
Primary completion
2018-10
Completion
2018-10

Outcome

Met primary endpoint

paper adjusted odds ratio, 1.61; 95% confidence interval [CI], 1.09 to 2.36; P=0.02 PMID 29766770 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 0.9 mg/kg Intravenous

Indications